267 related articles for article (PubMed ID: 15930280)
1. EphB4 expression and biological significance in prostate cancer.
Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of EphB4 in mesothelioma and its biological significance.
Xia G; Kumar SR; Masood R; Koss M; Templeman C; Quinn D; Zhu S; Reddy R; Krasnoperov V; Gill PS
Clin Cancer Res; 2005 Jun; 11(12):4305-15. PubMed ID: 15958611
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
4. Calpain-2 as a target for limiting prostate cancer invasion.
Mamoune A; Luo JH; Lauffenburger DA; Wells A
Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643
[TBL] [Abstract][Full Text] [Related]
5. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
[TBL] [Abstract][Full Text] [Related]
6. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
[TBL] [Abstract][Full Text] [Related]
8. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
Gao AC; Lou W; Isaacs JT
Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.
You Z; Shi XB; DuRaine G; Haudenschild D; Tepper CG; Lo SH; Gandour-Edwards R; de Vere White RW; Reddi AH
Cancer Res; 2006 Jan; 66(1):175-83. PubMed ID: 16397230
[TBL] [Abstract][Full Text] [Related]
11. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
13. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
14. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
[TBL] [Abstract][Full Text] [Related]
15. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Id1 by small interfering RNA in prostate cancer PC3 cells in vivo and in vitro.
Ling YX; Tao J; Fang SF; Hui Z; Fang QR
Eur J Cancer Prev; 2011 Jan; 20(1):9-17. PubMed ID: 20881502
[TBL] [Abstract][Full Text] [Related]
17. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
18. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
19. Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model.
Bisanz K; Yu J; Edlund M; Spohn B; Hung MC; Chung LW; Hsieh CL
Mol Ther; 2005 Oct; 12(4):634-43. PubMed ID: 16039164
[TBL] [Abstract][Full Text] [Related]
20. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]